PI3K-IN-28 is a potent PI3K inhibitor with low cytotoxicity toward MCF-10a cells; it exhibits IC50 values of 5.8, 2.3, and 7.9 μM and a selectivity index (SI) of 39, making it a promising lead compound for further optimization of anticancer activity.